The Complex Genetic Landscape of Hereditary Ataxias in Turkey and Implications in Clinical Practice.


Journal

Movement disorders : official journal of the Movement Disorder Society
ISSN: 1531-8257
Titre abrégé: Mov Disord
Pays: United States
ID NLM: 8610688

Informations de publication

Date de publication:
07 2021
Historique:
revised: 06 01 2021
received: 13 10 2020
accepted: 15 01 2021
pubmed: 25 2 2021
medline: 30 7 2021
entrez: 24 2 2021
Statut: ppublish

Résumé

The genetic and epidemiological features of hereditary ataxias have been reported in several populations; however, Turkey is still unexplored. Due to high consanguinity, recessive ataxias are more common in Turkey than in Western European populations. To identify the prevalence and genetic structure of hereditary ataxias in the Turkish population. Our cohort consisted of 1296 index cases and 324 affected family members. Polymerase chain reaction followed by Sanger sequencing or fragment analysis were performed to screen for the trinucleotide repeat expansions in families with a dominant inheritance pattern, as well as in sporadic cases. The expansion in the frataxin (FXN) gene was tested in all autosomal recessive cases and in sporadic cases with a compatible phenotype. Whole-exome sequencing was applied to 251 probands, selected based on the family history, age of onset, and phenotype. Mutations in known ataxia genes were identified in 30% of 1296 probands. Friedreich's ataxia was found to be the most common recessive ataxia in Turkey, followed by autosomal recessive spastic ataxia of Charlevoix-Saguenay. Spinocerebellar ataxia types 2 and 1 were the most common dominant ataxias. Whole-exome sequencing was performed in 251 probands with an approximate diagnostic yield of 50%. Forty-eight novel variants were found in a plethora of genes, suggesting a high heterogeneity. Variants of unknown significance were discussed in light of clinical data. With the large sample size recruited across the country, we consider that our results provide an accurate picture of the frequency of hereditary ataxias in Turkey. © 2021 International Parkinson and Movement Disorder Society.

Sections du résumé

BACKGROUND
The genetic and epidemiological features of hereditary ataxias have been reported in several populations; however, Turkey is still unexplored. Due to high consanguinity, recessive ataxias are more common in Turkey than in Western European populations.
OBJECTIVE
To identify the prevalence and genetic structure of hereditary ataxias in the Turkish population.
METHODS
Our cohort consisted of 1296 index cases and 324 affected family members. Polymerase chain reaction followed by Sanger sequencing or fragment analysis were performed to screen for the trinucleotide repeat expansions in families with a dominant inheritance pattern, as well as in sporadic cases. The expansion in the frataxin (FXN) gene was tested in all autosomal recessive cases and in sporadic cases with a compatible phenotype. Whole-exome sequencing was applied to 251 probands, selected based on the family history, age of onset, and phenotype.
RESULTS
Mutations in known ataxia genes were identified in 30% of 1296 probands. Friedreich's ataxia was found to be the most common recessive ataxia in Turkey, followed by autosomal recessive spastic ataxia of Charlevoix-Saguenay. Spinocerebellar ataxia types 2 and 1 were the most common dominant ataxias. Whole-exome sequencing was performed in 251 probands with an approximate diagnostic yield of 50%. Forty-eight novel variants were found in a plethora of genes, suggesting a high heterogeneity. Variants of unknown significance were discussed in light of clinical data.
CONCLUSION
With the large sample size recruited across the country, we consider that our results provide an accurate picture of the frequency of hereditary ataxias in Turkey. © 2021 International Parkinson and Movement Disorder Society.

Identifiants

pubmed: 33624863
doi: 10.1002/mds.28518
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1676-1688

Informations de copyright

© 2021 International Parkinson and Movement Disorder Society.

Références

Coutelier M, Hammer MB, Stevanin G, et al. Efficacy of exome-targeted capture sequencing to detect mutations in known cerebellar ataxia genes. JAMA Neurol 2018;75(5):591-599. https://doi.org/10.1001/jamaneurol.2017.5121
Pyle A, Smertenko T, Bargiela D, et al. Exome sequencing in undiagnosed inherited and sporadic ataxias. Brain 2015;138(2):276-283. https://doi.org/10.1093/brain/awu348
Fogel BL, Lee H, Deignan JL, et al. Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia. JAMA Neurol 2014;71(10):1237-1246. https://doi.org/10.1001/jamaneurol.2014.1944
Divya KP, Kishore A. Treatable cerebellar ataxias. Clin Parkinsonism Relat Disord 2020;3. https://doi.org/10.1016/j.prdoa.2020.100053
Synofzik M, Schüle R. Overcoming the divide between ataxias and spastic paraplegias: shared phenotypes, genes, and pathways. Mov Disord 2017;32(3):332-345. https://doi.org/10.1002/mds.26944
Parkinson MH, Boesch S, Nachbauer W, Mariotti C, Giunti P. Clinical features of Friedreich's ataxia: classical and atypical phenotypes. J Neurochem 2013;126(1):103-117. https://doi.org/10.1111/jnc.12317
Naeije G, Wens V, Coquelet N, et al. Age of onset determines intrinsic functional brain architecture in Friedreich ataxia. Ann Clin Transl Neurol 2020;7(1):94-104. https://doi.org/10.1002/acn3.50966
Candayan A, Yunisova G, Çakar A, et al. The first biallelic missense mutation in the FXN gene in a consanguineous Turkish family with Charcot-Marie-Tooth-like phenotype. Neurogenetics 2020;21(1):73-78. https://doi.org/10.1007/s10048-019-00594-1
Cortese A, Simone R, Sullivan R, et al. Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia. Nat Genet 2019;51:649-658. https://doi.org/10.1038/s41588-019-0372-4
Traschütz A, Cortese A, Reich S, et al. Natural History, Phenotypic Spectrum, and Discriminative Features of Multisystemic RFC1-disease. Neurology. 2021; https://doi.org/10.1212/WNL.0000000000011528
Dürr A. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol 2010;9:885-894. https://doi.org/10.1016/S1474-4422(10)70183-6
Ruano L, Melo C, Silva MC, Coutinho P. The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology 2014;42(3):174-183. https://doi.org/10.1159/000358801
Schols L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004;3(5):291-304. https://doi.org/10.1016/S1474-4422(04)00737-9
Tsuji S. Dentatorubral-pallidoluysian atrophy. Handb Clin Neurol 2012;103:587-594. https://doi.org/10.1016/B978-0-444-51892-7.00041-3
Klockgether T, Mariotti C, Paulson HL. Spinocerebellar ataxia. Nat Rev Dis Primers 2019;5(1):24. https://doi.org/10.1038/s41572-019-0074-3
Velazquez-Perez LC, Rodriguez-Labrada R, Fernandez-Ruiz J. Spinocerebellar ataxia type 2: clinicogenetic aspects, mechanistic insights, and management approaches. Front Neurol 2017;8:472. https://doi.org/10.3389/fneur.2017.00472
Rossi M, Perez-Lloret S, Doldan L, et al. Autosomal dominant cerebellar ataxias: a systematic review of clinical features. Eur J Neurol 2014;21(4):607-615. https://doi.org/10.1111/ene.12350
Van de Warrenburg BPC, Sinke RJ, Verschuuren-Bemelmans CC, et al. Spinocerebellar ataxias in the Netherlands: prevalence and age at onset variance analysis. Neurology 2002;58(5):702-708. https://doi.org/10.1212/WNL.58.5.702
Akbayram S, Sari N, Akgün C, et al. The frequency of consanguinous marriages in eastern Turkey. Genet Counsel 2009;20(3):207-214.
Dürr A, Cossee M, Agid Y, et al. Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med 1996;335(16):1169-1175. https://doi.org/10.1056/NEJM199610173351601
Reetz K, Dogan I, Costa AS, et al. Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data. Lancet Neurol 2015;14(2):174-182. https://doi.org/10.1016/S1474-4422(14)70321-7
Synofzik M, Nemeth AH. Recessive ataxias. Handb Clin Neurol 2018;155:73-89. https://doi.org/10.1016/B978-0-444-64189-2.00005-6
Synofzik M, Puccio H, Mochel F, Schöls L. Autosomal recessive cerebellar ataxias: paving the way toward targeted molecular therapies. Neuron 2019;101(4):560-583. https://doi.org/10.1016/j.neuron.2019.01.049
Emekli AS, Samanci B, Şimşir G, et al. A novel PNPLA6 mutation in a Turkish family with intractable Holmes tremor and spastic ataxia. Neurol Sci 2020. https://doi.org/10.1007/s10072-020-04869-6
Coutelier M, Stevanin G, Brice A. Genetic landscape remodelling in spinocerebellar ataxias: the influence of next-generation sequencing. J Neurol 2015;262:2382-2395. https://doi.org/10.1007/s00415-015-7725-4
TÜİK. Turkish Statistical Institute [homepage on the Internet]. 2019. https://data.tuik.gov.tr/en/main-category-sub-categories-sub-components2/. Accessed October 13, 2020.
Albayrak-Mutlu H, Kırat E, Gürbüz G. Childhood-onset autosomal recessive ataxias: a cross-sectionalstudy from Turkey. Neurogenetics 2020;21:59-66. https://doi.org/10.1007/s10048-019-00597-y
Arslan E, Öncel I, Ceylan AC, Topçu M, Topaloğlu H. Genetic and phenotypic features of patients with childhoodataxias diagnosed by next-generation sequencing gene panel. Brain Dev 2020;42(1):6-18. https://doi.org/10.1016/j.braindev.2019.08.004
Sayan S, Kotan D, Gündoğdu-Eken A, Şahbaz I, Koçoğlu C, Başak AN. Phenotypic and genotypic analysis of hereditary ataxia patients in Sakarya city, Turkey. Arch Neuropsychiatry 2019;56:106-109. https://doi.org/10.5152/npa.2017.20525
Soysal A, Çetin S, Özer F, Doğu O, Sarı H, Arpacı B. Herediter ataksilerin sınıflandırılması. Turkish J Neurol 1995;1(4):226-231.

Auteurs

Atay Vural (A)

Department of Neurology, School of Medicine, Koç University, İstanbul, Turkey.

Gülşah Şimşir (G)

Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, KUTTAM, School of Medicine, Koç University, İstanbul, Turkey.

Şeyma Tekgül (Ş)

Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, KUTTAM, School of Medicine, Koç University, İstanbul, Turkey.

Cemile Koçoğlu (C)

Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, Department of Molecular Biology and Genetics, Boğaziçi University, İstanbul, Turkey.

Fulya Akçimen (F)

Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, Department of Molecular Biology and Genetics, Boğaziçi University, İstanbul, Turkey.

Ece Kartal (E)

Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, Department of Molecular Biology and Genetics, Boğaziçi University, İstanbul, Turkey.

Nesli E Şen (NE)

Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, Department of Molecular Biology and Genetics, Boğaziçi University, İstanbul, Turkey.

Suna Lahut (S)

Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, Department of Molecular Biology and Genetics, Boğaziçi University, İstanbul, Turkey.

Özgür Ömür (Ö)

Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, Department of Molecular Biology and Genetics, Boğaziçi University, İstanbul, Turkey.

Nazan Saner (N)

Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, Department of Molecular Biology and Genetics, Boğaziçi University, İstanbul, Turkey.

Tuğçe Gül (T)

Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, KUTTAM, School of Medicine, Koç University, İstanbul, Turkey.

Elif Bayraktar (E)

Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, KUTTAM, School of Medicine, Koç University, İstanbul, Turkey.

Robin Palvadeau (R)

Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, KUTTAM, School of Medicine, Koç University, İstanbul, Turkey.

Ceren Tunca (C)

Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, KUTTAM, School of Medicine, Koç University, İstanbul, Turkey.
Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, Department of Molecular Biology and Genetics, Boğaziçi University, İstanbul, Turkey.

Caroline Pirkevi Çetinkaya (C)

Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, KUTTAM, School of Medicine, Koç University, İstanbul, Turkey.
Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, Department of Molecular Biology and Genetics, Boğaziçi University, İstanbul, Turkey.

Aslı Gündoğdu Eken (A)

Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, Department of Molecular Biology and Genetics, Boğaziçi University, İstanbul, Turkey.

Irmak Şahbaz (I)

Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, KUTTAM, School of Medicine, Koç University, İstanbul, Turkey.
Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, Department of Molecular Biology and Genetics, Boğaziçi University, İstanbul, Turkey.

Müge Kovancılar Koç (M)

Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, KUTTAM, School of Medicine, Koç University, İstanbul, Turkey.
Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, Department of Molecular Biology and Genetics, Boğaziçi University, İstanbul, Turkey.

Özgür Öztop Çakmak (Ö)

Department of Neurology, School of Medicine, Koç University, İstanbul, Turkey.

Haşmet Hanağası (H)

Department of Neurology, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey.

Başar Bilgiç (B)

Department of Neurology, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey.

Mefkure Eraksoy (M)

Department of Neurology, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey.

Ayşegül Gündüz (A)

Department of Neurology, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkey.

Hülya Apaydın (H)

Department of Neurology, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkey.

Güneş Kızıltan (G)

Department of Neurology, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkey.

Sibel Özekmekçi (S)

Department of Neurology, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkey.

Aksel Siva (A)

Department of Neurology, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkey.

Ayşe Altıntaş (A)

Department of Neurology, School of Medicine, Koç University, İstanbul, Turkey.
Department of Neurology, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkey.

Zeynep E Kaya Güleç (ZE)

Department of Neurology, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkey.

Yeşim Parman (Y)

Department of Neurology, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey.

Piraye Oflazer (P)

Department of Neurology, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey.

Feza Deymeer (F)

Department of Neurology, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey.

Hacer Durmuş (H)

Department of Neurology, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey.

Erdi Şahin (E)

Department of Neurology, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey.

Arman Çakar (A)

Department of Neurology, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey.

Zeynep Tüfekçioğlu (Z)

Department of Neurology, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey.

Pınar Tektürk (P)

Department of Pediatric Neurology, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey.

M Osman Çorbalı (MO)

Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Turkey.

Hülya Tireli (H)

Department of Neurology, Haydarpaşa Numune Training and Research Hospital, İstanbul, Turkey.

Gülden Akdal (G)

Department of Neurology, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey.

Uluç Yiş (U)

Division of Child Neurology, Department of Pediatrics, School of Medicine, Dokuz Eylül University, İzmir, Turkey.

Semra Hız (S)

Division of Child Neurology, Department of Pediatrics, School of Medicine, Dokuz Eylül University, İzmir, Turkey.

İhsan Şengün (İ)

Division of Clinical Neurophysiology, Department of Neurology, Faculty of Medicine, Dokuz Eylül University, Izmir, Turkey.

Elçin Bora (E)

Department of Medical Genetics, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey.

Gül Serdaroğlu (G)

Division of Child Neurology, Department of Pediatrics, Ege University Medical School, İzmir, Turkey.

Sevda Erer Özbek (S)

Department of Neurology, Faculty of Medicine, Uludağ University, Bursa, Turkey.

Kadriye Ağan (K)

Department of Neurology, School of Medicine, Marmara University, İstanbul, Turkey.

Dilek İnce Günal (D)

Department of Neurology, School of Medicine, Marmara University, İstanbul, Turkey.

Önder Us (Ö)

Department of Neurology, Acıbadem Kozyatağı Hospital, İstanbul, Turkey.

Semiha G Kurt (SG)

Department of Neurology, School of Medicine, Tokat Gaziosmanpaşa University, Tokat, Turkey.

Dürdane Aksoy (D)

Department of Neurology, School of Medicine, Tokat Gaziosmanpaşa University, Tokat, Turkey.

Ayşe Bora Tokçaer (A)

Department of Neurology, Faculty of Medicine, Gazi University, Ankara, Turkey.

Muhsin Elmas (M)

Department of Medical Genetics, Faculty of Medicine, Afyon Kocatepe University, Afyonkarahisar, Turkey.

Murat Gültekin (M)

Department of Neurology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.

Sefer Kumandaş (S)

Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Erciyes University, Kayseri, Turkey.

Hamit Acer (H)

Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Erciyes University, Kayseri, Turkey.

Gül D Kaya Özçora (GD)

Department of Pediatric Neurology, Kayseri Training and Research City Hospital, Kayseri, Turkey.

Vildan Yayla (V)

Department of Neurology, Bakırköy Dr. Sadi Konuk Research and Training Hospital, İstanbul, Turkey.

Aysun Soysal (A)

Department of Neurology, Bakırköy Training and Research Hospital for Psychiatry, Neurology, Neurosurgery, İstanbul, Turkey.

Gençer Genç (G)

Department of Neurology, University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital, İstanbul, Turkey.

Halil Güllüoğlu (H)

Department of Neurology, Medical Park İzmir Hospital, İzmir, Turkey.

Dilcan Kotan (D)

Department of Neurology, Faculty of Medicine, Sakarya University, Sakarya, Turkey.

Zeynep Özözen Ayas (Z)

Department of Neurology, Eskişehir City Hospital, Eskişehir, Turkey.

Hüseyin A Şahin (HA)

Department of Neurology, School of Medicine, Ondokuz Mayıs University, Samsun, Turkey.

Ersin Tan (E)

Department of Neurology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

Meral Topçu (M)

Department of Neurology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

Esen Saka Topçuoğlu (ES)

Department of Neurology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

Cenk Akbostancı (C)

Department of Neurology, Faculty of Medicine, Ankara University, Ankara, Turkey.

Filiz Koç (F)

Department of Neurology, Çukurova University, School of Medicine, Adana, Turkey.

Sibel Ertan (S)

Department of Neurology, School of Medicine, Koç University, İstanbul, Turkey.
Department of Neurology, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkey.

Bülent Elibol (B)

Department of Neurology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

A Nazlı Başak (AN)

Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, KUTTAM, School of Medicine, Koç University, İstanbul, Turkey.
Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory, Department of Molecular Biology and Genetics, Boğaziçi University, İstanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH